Case series:pemetrexed

2 trials

Sponsors

Fujian Tumor Hospital, Huashan Hospital North, Fudan University

Conditions

adenocarcinoma lung cancerprimary central nervous system lymphoma

Phase 2

Osimertinib combined with Pemetrexed compared to Osimertinib monotherapy in the treatment of patients EGFR T790M–Positive Lung Cancer: a prospective, phase II randomized controlled trial

Active, not recruitingChiCTR1800019710

Fujian Tumor Hospitaladenocarcinoma lung cancer

Start: 2019-12-01Updated: 2018-11-26

Phase II clinical study of pemetrexed combined with lenalidomide in the treatment of relapsed/refractory primary central nervous system lymphoma

RecruitingChiCTR1900028070

Huashan Hospital North, Fudan Universityprimary central nervous system lymphoma

Start: 2018-06-01Updated: 2019-12-16

Related Papers

Pemetrexed Plus Lenalidomide for Relapsed/Refractory Primary Central Nervous System Lymphoma: A Prospective Single-Arm Phase II Study

Frontiers in Oncology2022-07-116 citations